M J Leal-Witt1,2, M Ramon-Krauel1,2, S Samino3,4, M Llobet1,2, D Cuadras5, J C Jimenez-Chillaron1,2, O Yanes3,4, C Lerin1,2. 1. Department of Endocrinology, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. 2. Hospital Sant Joan de Déu Barcelona, Barcelona, Spain. 3. Metabolomics Platform, Department of Electronic Engineering (DEEEA), Universitat Rovira i Virgili, Tarragona, Spain. 4. Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain. 5. Department of Statistics, Sant Joan de Déu Research Foundation, Barcelona, Spain.
Abstract
OBJECTIVE: Childhood obesity is a strong risk factor for adult obesity and metabolic diseases, including type 2 diabetes and cardiovascular disease. Early lifestyle intervention in children with obesity reduces future disease risk. The objective of this study is to identify metabolic signatures associated with lifestyle intervention in prepubertal children with obesity. METHODS: Thirty-five prepubertal children (7-10 years) with obesity (body mass index (BMI)>2 standard deviations) were enrolled in the study and participated in a 6-month-long lifestyle intervention program. Physiological and biochemical data and blood samples were collected both at baseline and after the intervention. A liquid chromatography-mass spectrometry (LC-MS)-based metabolomics approach was applied to obtain a comprehensive profiling of plasma samples, identifying 2581 distinct metabolite. Principal component analysis (PCA) was performed to consolidate all features into 8 principal components. Associations between metabolites and physiological and biochemical variables were investigated. RESULTS: The intervention program significantly decreased mean (95% CI) BMI standard deviation score from 3.56 (3.29-3.84) to 3.11 (2.88-3.34) (P<0.001). PCA identified one component (PC1) significantly altered by the intervention (Bonferroni adjusted P=0.008). A sphingolipid metabolism-related signature was identified as the major contributor to PC1. Sphingolipid metabolites were decreased by the intervention, and included multiple sphingomyelin, ceramide, glycosylsphingosine and sulfatide species. Changes in several sphingolipid metabolites were associated with intervention-induced improvements in HbA1c levels. CONCLUSIONS: Decreased circulating sphingolipid-related metabolites were associated with lifestyle intervention in prepubertal children with obesity, and correlated to improvements in HbA1c.
OBJECTIVE: Childhood obesity is a strong risk factor for adult obesity and metabolic diseases, including type 2 diabetes and cardiovascular disease. Early lifestyle intervention in children with obesity reduces future disease risk. The objective of this study is to identify metabolic signatures associated with lifestyle intervention in prepubertal children with obesity. METHODS: Thirty-five prepubertal children (7-10 years) with obesity (body mass index (BMI)>2 standard deviations) were enrolled in the study and participated in a 6-month-long lifestyle intervention program. Physiological and biochemical data and blood samples were collected both at baseline and after the intervention. A liquid chromatography-mass spectrometry (LC-MS)-based metabolomics approach was applied to obtain a comprehensive profiling of plasma samples, identifying 2581 distinct metabolite. Principal component analysis (PCA) was performed to consolidate all features into 8 principal components. Associations between metabolites and physiological and biochemical variables were investigated. RESULTS: The intervention program significantly decreased mean (95% CI) BMI standard deviation score from 3.56 (3.29-3.84) to 3.11 (2.88-3.34) (P<0.001). PCA identified one component (PC1) significantly altered by the intervention (Bonferroni adjusted P=0.008). A sphingolipid metabolism-related signature was identified as the major contributor to PC1. Sphingolipid metabolites were decreased by the intervention, and included multiple sphingomyelin, ceramide, glycosylsphingosine and sulfatide species. Changes in several sphingolipid metabolites were associated with intervention-induced improvements in HbA1c levels. CONCLUSIONS: Decreased circulating sphingolipid-related metabolites were associated with lifestyle intervention in prepubertal children with obesity, and correlated to improvements in HbA1c.
Authors: Asma Ejaz; Laura Martinez-Guino; Allison B Goldfine; Francesc Ribas-Aulinas; Valeria De Nigris; Sílvia Ribó; Alba Gonzalez-Franquesa; Pablo M Garcia-Roves; Elizabeth Li; Jonathan M Dreyfuss; Walt Gall; Jason K Kim; Teodoro Bottiglieri; Francesc Villarroya; Robert E Gerszten; Mary-Elizabeth Patti; Carles Lerin Journal: Diabetes Date: 2016-02-08 Impact factor: 9.461
Authors: Hazel Huang; Takhar Kasumov; Patrick Gatmaitan; Helen M Heneghan; Sangeeta R Kashyap; Philip R Schauer; Stacy A Brethauer; John P Kirwan Journal: Obesity (Silver Spring) Date: 2011-05-05 Impact factor: 5.002
Authors: Jonathan Y Xia; William L Holland; Christine M Kusminski; Kai Sun; Ankit X Sharma; Mackenzie J Pearson; Angelika J Sifuentes; Jeffrey G McDonald; Ruth Gordillo; Philipp E Scherer Journal: Cell Metab Date: 2015-07-16 Impact factor: 27.287
Authors: Erin L Glynn; Lucy W Piner; Kim M Huffman; Cris A Slentz; Lorraine Elliot-Penry; Hiba AbouAssi; Phillip J White; James R Bain; Michael J Muehlbauer; Olga R Ilkayeva; Robert D Stevens; Kathryn N Porter Starr; Connie W Bales; Elena Volpi; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Christopher B Newgard; William E Kraus Journal: Diabetologia Date: 2015-08-09 Impact factor: 10.122
Authors: Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey Journal: Cell Metab Date: 2009-04 Impact factor: 27.287
Authors: John R Ussher; Timothy R Koves; Virgilio J J Cadete; Liyan Zhang; Jagdip S Jaswal; Suzanne J Swyrd; David G Lopaschuk; Spencer D Proctor; Wendy Keung; Deborah M Muoio; Gary D Lopaschuk Journal: Diabetes Date: 2010-06-03 Impact factor: 9.461
Authors: Geoffrey A Walford; Yong Ma; Clary Clish; Jose C Florez; Thomas J Wang; Robert E Gerszten Journal: Diabetes Date: 2016-02-09 Impact factor: 9.461
Authors: Samuel Manzano-Carrasco; Jose Luis Felipe; Javier Sanchez-Sanchez; Antonio Hernandez-Martin; Ivan Clavel; Leonor Gallardo; Jorge Garcia-Unanue Journal: Int J Environ Res Public Health Date: 2020-05-11 Impact factor: 3.390
Authors: Nasser M Al-Daghri; Enrica Torretta; Pietro Barbacini; Hannah Asare; Cristian Ricci; Daniele Capitanio; Franca Rosa Guerini; Shaun B Sabico; Majed S Alokail; Mario Clerici; Cecilia Gelfi Journal: Sci Rep Date: 2019-11-13 Impact factor: 4.379
Authors: Siri D Taxerås; María Galán; Laura Campderros; Irene Piquer-Garcia; Silvia Pellitero; Eva Martínez; Rocío Puig; Icíar Lucena; Jordi Tarascó; Pau Moreno; José Balibrea; Joan Bel; Marta Murillo; María Martínez; Marta Ramon-Krauel; Manel Puig-Domingo; Francesc Villarroya; Carles Lerin; David Sánchez-Infantes Journal: Obes Sci Pract Date: 2019-12-02